Interesting point. Keep in mind though for Bio tec
Post# of 75011
BT's are very risky too for the most part. Many of them don't have or will never have good revenues because a lot of them invest a lot of money in the hopes of getting FDA approval; some make it to the promise land though but most don't because there's a lot of FDA rejections or many set backs along the way to getting approved.
In mean time, they still have to pay for operations, employees, etc.
Kind of outside the topic of RMHB when comparing BT's because they're a completely different animal compared to what RMHB specializes in and what they do.
Hope this helps!